Nirvana Life Sciences Inc. (CSE:NIRV.X)
Canada · Delayed Price · Currency is CAD 0.0500
0.00 (0.00%)
At close: Sep 4, 2026
Nirvana Life Sciences Market Cap
Nirvana Life Sciences has a market cap or net worth of CAD 1.15 million as of October 9, 2026. It is the 49,760th most valuable company in the world and the 2,470th biggest in Canada. Its market cap has increased by 179.57% in one year.
Market Cap
1.15M
Enterprise Value
1.28M
Revenue
n/a
Global Rank
Country Rank
#2,470 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since March 17, 2022, Nirvana Life Sciences's market cap has decreased from 4.27M to 1.15M, a decrease of -73.15%. That is a compound annual growth rate of -25.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.15M | -33.33% |
| Dec 29, 2025 | 1.72M | -28.71% |
| Dec 27, 2024 | 2.41M | 150.00% |
| Dec 28, 2023 | 964.66K | -81.10% |
| Dec 19, 2022 | 5.10M | 19.58% |
| Mar 17, 2022 | 4.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FLUENT | 18.21M |
| Refined Energy | 9.31M |
| LIR Life Sciences | 6.31M |
| Promino Nutritional Sciences | 5.38M |
| Appili Therapeutics | 1.32M |
| EGF Theramed Health | 638.92K |
| Else Nutrition Holdings | 622.62K |
| Digicann Ventures | 601.38K |